Review article<br>Efficacy of different interferon beta preparations in multiple sclerosis.
Review of open label comparative studies

Tomasz Berkowicz

eISSN: 2084-9885
ISSN: 1896-6764

Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Open access

4/2012
vol. 7

Send email

Copy url:

abstract:

Review article
Efficacy of different interferon beta preparations in multiple sclerosis. Review of open label comparative studies

Tomasz Berkowicz

Neuropsychiatria i Neuropsychologia 2012; 7, 4: 175–180

Online publish date: 2013/01/31

View full text Get citation

Beta interferon is the first-line immunomodulatory agent approved for remitting-relapsing multiple sclerosis. Several preparations of interferon beta 1b and interferon beta 1a are available for treatment. The author reviews the publications on 13 open-label studies comparing the efficacy of interferon beta preparations. Based on current clinical data we can conclude that differences in efficacy between various preparations of beta interferon are subtle and often undetectable. Therefore, the individual patient response to particular treatment, tolerability, administration route, compliance and costs of the treatment should determine the therapeutic decision.

keywords:

Review articleEfficacy of different interferon beta preparations in multiple sclerosis. Review of open label comparative studies

Tomasz Berkowicz

interferon β, efficacy, multiple sclerosis

Review article
Efficacy of different interferon beta preparations in multiple sclerosis. Review of open label comparative studies